Analyzing willingness for extracorporeal cardiopulmonary resuscitation in refractory ventricular fibrillation

PLoS One. 2023 Jan 26;18(1):e0281092. doi: 10.1371/journal.pone.0281092. eCollection 2023.

Abstract

Extracorporeal cardiopulmonary resuscitation (ECPR) for refractory ventricular fibrillation/ventricular tachycardia in out-of-hospital cardiac arrest has recently been recommended for selected patients with favorable prognostic features. We aimed to identify factors affecting the willingness of emergency physicians to implement extracorporeal cardiopulmonary resuscitation (ECPR). We conducted a factorial survey with nine experimental vignettes by combining three different scene time intervals and transportation time intervals. Emergency physicians reported willingness to implement ECPR (1-100 points). Respondent characteristics that could affect the willingness were studied. Multilevel analysis of vignettes and respondent factors was conducted using a mixed-effects regression model. We obtained 486 vignette responses from 54 emergency physicians. In the case of longer scene time intervals, there was a significant difference in the willingness scores at 9 and 12 min transportation time intervals. When the pre-hospital time interval was > 40 min, emergency physicians demonstrated lower willingness to implement ECPR. Clinical experience of 15-19 years showed a significant favorable effect on willingness to implement extracorporeal membrane oxygenation (ECMO). However, the mean willingness scores of EPs for ECMO implementation were more than 75 across all vignettes. In ECPR, the prehospital time interval is an important factor, and the willingness of emergency physicians to implement ECMO could be mutually affected by scene time intervals, transportation time intervals, and total prehospital time.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiopulmonary Resuscitation*
  • Extracorporeal Membrane Oxygenation*
  • Humans
  • Out-of-Hospital Cardiac Arrest* / therapy
  • Retrospective Studies
  • Surveys and Questionnaires
  • Ventricular Fibrillation / therapy

Grants and funding

Financial support for this study was provided in part by a grant from Hallym University Research Fund 2020 (HURF-2020-32). The funding agreement ensured the authors’ independence in designing the study, interpreting the data, writing, and publishing the report.